We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · July 28, 2021

Immunosuppressants in Steroid-Refractory/Resistant Immune-Related Adverse Events

Journal of Thoracic Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Thoracic Oncology
Beyond Steroids: Immunosuppressants in Steroid-Refractory/Resistant Immune Related Adverse Events
J Thorac Oncol 2021 Jul 12;[EPub Ahead of Print], J Luo, JA Beattie, P Fuentes, H Rizvi, JV Egger, JA Kern, DYM Leung, ME Lacouture, MG Kris, M Gambarin, BD Santomasso, DM Faleck, MD Hellmann

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading